Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation.
Cytochrome oxidase activity was examined in a transgenic mouse model of Alzheimer's disease with overexpression of the 751 amino acid isoform of beta-amyloid precursor protein with the Swedish mutation under control of the murine thy-1 promoter. The neuritic plaques, abundantly localized in the hippocampus and anterior neocortical areas, showed a core devoid of enzymatic activity surrounded by higher cytochrome oxidase activity at the sites of the dystrophic neurites and activated glial cells. Quantitative measures, taken only in the healthy-appearing regional areas without neuritic plaques, were higher in numerous limbic and non-limbic regions of transgenic mice in comparison with controls. Enzymatic activity was higher in the dentate gyrus and CA2-CA3 region of the hippocampus, the anterior cingulate and primary visual cortex, two olfactory structures, the ventral part of the neostriatum, the parafascicularis nucleus of the thalamus, and the subthalamic nucleus. Brainstem regions anatomically related with altered forebrain regions were more heavily labeled as well, including the substantia nigra, the periaqueductal gray, the superior colliculus, the medial raphe, the locus coeruleus and the adjacent parabrachial nucleus, as well as the pontine nuclei, red nucleus, and trigeminal motor nucleus. Functional brain organization is discussed in the context of Alzheimer's disease. Although hypometabolism is generally observed in this pathology, the increased cytochrome oxidase activity obtained in these transgenic mice can be the result of a functional compensation on the surviving neurons, or of an early mitochondrial alteration related to increased oxidative damage.
Laboratoire de Pathologie Moléculaire et Cellulaire en Nutrition and the Service de Microscopie Electronique, Faculté de Médecine, Université Henri Poincaré, 7 Allée de la Forêt de Haye, 54500 Vandoeuvre-les-Nancy, France. straziel@persmail.uhp-nancy.fr
C
C
Strazielle
C
C
Sturchler-Pierrat
M
M
Staufenbiel
R
R
Lalonde
D000544:Alzheimer Disease / Q000201:enzymology / Q000473:pathology; D016564:Amyloid beta-Protein Precursor / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000201:enzymology*; D001931:Brain Mapping; D016022:Case-Control Studies; D003720:Densitometry / Q000379:methods; D004195:Disease Models, Animal; D003576:Electron Transport Complex IV / Q000378:metabolism*; D005260:Female; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009046:Motor Neurons / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D011401:Promoter Regions, Genetic; D018800:Thy-1 Antigens / Q000235:genetics / Q000378:metabolism
D016564:Amyloid beta-Protein Precursor; D018800:Thy-1 Antigens; D003576:Electron Transport Complex IV